HANNAH DEVAZIER: Open Payments
NPI 1720552755 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 16 payments from 10 companies in 2025. Trend: 2023 $553 · 2024 $1,109 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Boston Scientific Corporation | 1 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $33 |
| ABBVIE INC. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: NUZYRA, JARDIANCE, WATCHMAN FLX, LifeVest, QULIPTA, FARXIGA, ACCRUFER, Saxenda.
Industry payments across MS — which companies pay providers there.
